HBsAg Related Response Guided Therapy

NCT01456312 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Peginterferon alfa-2a
DRUG: Entecavir

Sponsor

Gangnam Severance Hospital

Collaborators

[object Object]